Development of new gene therapy vectors and the preclinical cancer animal model system using common marmoset

点击翻译按钮获取中文摘要

To develop new therapies for cancer, we have been involved in the development of new animal cancer models and new gene therapy methods. During the past 5 years, we could successfully develop human T-lymphotropic virus (HTLV)-1 carrier model in small monkey of common marmoset. This animal model will become very helpful to elucidate pathophysiology of human adult T-cell leukemia and to develop its new therapeutic modality. We also developed new oncolytic virus gene therapy methods using measles virus and enterovirus, and new immune gene therapy method using GM-CSF expressing carrier cells. We are now preparing the phase I clinical study using this new gene therapy method.